Who are the top Indian pioglitazone exporters/manufacturers?

The top Indian pioglitazone exporters in 2025-Q4 include AUROBINDO PHARMA LTD. 25 Indian companies exported pioglitazone to 30 countries, with total trade value of $2.6M. This report ranks all 25 suppliers by trade value with detailed profiles.

What is the price of Indian pioglitazone exports?

Indian pioglitazone export prices vary by dosage form, destination, and volume. This report provides median prices, price distribution (P5-P95), supplier-level pricing, and a country-by-dosage price matrix — based on 182 real customs shipments.

How to find Indian pioglitazone suppliers/manufacturers?

This free report lists all 25 Indian pioglitazone manufacturers/exporters ranked by trade value, with city, dosage forms, destination countries, and buyer portfolios. Top suppliers get 2-page profiles with trade flow maps.

PHARMA TRADE INTELLIGENCE

INDIA EXPORT INTELLIGENCE REPORT

Pioglitazone

2025-Q4

Comprehensive analysis of India’s pioglitazone export trade — suppliers, buyers, prices, routes, and every shipment record.

182

Shipments

$2.56M

Trade Value

25

Suppliers

45

Buyers

30

Countries

Scan for online report

Talk to our analyst: +91 95950 78788

https://transdatanexus.com/pharmaceutical/pioglitazone

01

PART I — OVERVIEW

Executive Summary

At-a-glance KPIs, key findings, and strategic positioning of India’s pioglitazone trade — 2025-Q4

KEY TAKEAWAY Pioglitazone 2025-Q4 exports total $2.6M across 30 countries, with AUROBINDO PHARMA LTD commanding 62.0% market share.

TOTAL SHIPMENTS

182

2025-Q4

EXPORT VALUE

$2.6M

FOB USD

TOTAL QUANTITY

92.4M

units shipped

INDIAN SUPPLIERS

25

unique exporters

GLOBAL BUYERS

45

unique importers

DESTINATIONS

30

countries

MEDIAN UNIT PRICE

$0.024

per unit

TOP-5 SHARE

91.0%

of total USD

BRANDED SHARE

47.3%

86 shipments

DOSAGE FORMS

2

product types

6 KEY FINDINGS

1

AUROBINDO PHARMA LTD is India's #1 Pioglitazone exporter with $1.6M (62.0% market share).→ §5, Indian Supplier Rankings

2

Pioglitazone reached 30 countries, with United States as the top destination ($1.6M).→ §4, Global Destination Map

3

Market concentration is high (HHI: 4199) — top 10 suppliers control 96.6% of exports.→ §5, Indian Supplier Rankings

4

91.1% of buyers (41 of 45) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings

5

Tablet dominates (99.4%) across 2 dosage forms.→ §7, Price Benchmarks

6

30 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities

WHO THIS REPORT IS FOR

S SUPPLIERS (Indian pharma exporters)

See which buyers your competitors are shipping to, at what price, through which ports
Identify buyers that are single-sourced (poaching opportunities)
Benchmark your pricing and catalog vs the Top 25

B BUYERS (global importers)

Discover which Indian exporters supply this product and what they sell
Benchmark the price you are paying vs the market median by country and dosage
Identify alternative suppliers with proven exports to similar destinations

Figure 1.1 AUROBINDO PHARMA LTD leads in volume — how do 25 exporters compare on price × volume?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Every bubble is one Indian pioglitazone exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.

HOW TO READ THIS REPORT

60 seconds

Scan this page — KPIs, thesis, flagship chart, top findings

5 minutes

Read every Key Takeaway line across §1–§9

30 minutes

Read sections tagged for your role ([S] or [B]) end-to-end

In depth

Drill into §10 for your country · supplier / buyer directories at end

02

PART I — OVERVIEW

About This Report

Data sources, methodology, trust signals, and what this Pioglitazone report covers

KEY TAKEAWAY Every figure in this report is grounded in real commercial pioglitazone trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.

S FOR SUPPLIERS

Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.

B FOR BUYERS

Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian pioglitazone suppliers.

§2.1 Reporting parameters · the scope of this 2025-Q4 Pioglitazone India trade report

P

Product scope

Pioglitazone

All variants merged — branded and generic formulations of pioglitazone

T

Time period

2025-Q4

October, November, December 2025 — a single-quarter snapshot

S

Data sources

Official & public trade records

Government customs filings, public trade databases and licensed commercial feeds

G

Geography

India origin → global

Indian sea and air ports shipping to destination markets worldwide

C

Currency

USD (FOB)

Declared Free-on-Board value at the Indian port of loading

R

Shipments analysed

182

Every commercial pioglitazone trade record in the period, aggregated and deduplicated

§2.2 Our quality process · Figure 2.1

Figure 2.1 From raw trade records to a clean report — the four quality pillars.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.

§2.3 Trust signals · what you can rely on in the numbers you read

DATA COVERAGE

10M+

Pharmaceutical trade records across the full TransData Nexus platform.

COUNTRIES

150+

Origin and destination countries covered in the global pharma trade database.

DATA ACCURACY

99.9%

Validation rate on core fields — supplier, buyer, product, quantity, value.

UPDATE FREQUENCY

Daily

Platform refresh cadence. This report is a snapshot from the same live data.

§2.4 Limitations · what the data does and does not tell you

WHAT THIS DATA DOES AND DOES NOT SAY

Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.

03

PART II — MARKET STRUCTURE

Quarterly Trade Overview

Monthly trends, regional performance, and ranking shifts — 2025-Q4

KEY TAKEAWAY 2025-Q4 followed a v-curve: Oct $1.0M, Nov $356.3K, Dec $1.2M. Shipment counts rose across the quarter.

S FOR SUPPLIERS

Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.

B FOR BUYERS

Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.

1

$1.0M

Oct USD

57 shipments

2

$356.3K

Nov USD

-65.9% MoM

3

$1.2M

Dec USD

+224.5% MoM

4

V-curve

Q4 growth shape

Oct → Nov → Dec

Fig 3.1 Nov dipped 65.9% in USD but shipment count kept climbing.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.0M, making it the middle month by value.

Fig 3.2 Q4 cumulative USD reached $2.6M.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.

Fig 3.3 $690K dip in Nov, $800K recovery in Dec.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.

Fig 3.4 Regional breakdown by month — which corridors swung most?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.

§3.1 Monthly summary

Oct	$1.0M	57 shipments
Nov	$356K	62 shipments
Dec	$1.2M	63 shipments
Q4 Total	$2.6M	182 shipments

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.

Fig 3.6 Top 10 Indian exporters by monthly USD rank.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: AUROBINDO PHARMA LTD maintained its leading position.

04

PART II — MARKET STRUCTURE

Global Destination Map

Which countries import pioglitazone from India, how much they buy, and who supplies each market

KEY TAKEAWAY United States absorbs 62.7% of India’s 2025-Q4 pioglitazone trade ($1.6M). Beyond the top 10 destinations, 30 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Europe has 8 destination countries, the widest regional diversity.

S FOR SUPPLIERS

Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 30 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.

B FOR BUYERS

Find your country on the map to see how much pioglitazone India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.

Asia

$271K

10.6% of trade

8 countries · 40 shipments

Europe

$137K

5.4% of trade

8 countries · 59 shipments

Americas

$2.1M

81.2% of trade

7 countries · 73 shipments

Africa

$73K

2.8% of trade

5 countries · 8 shipments

Oceania

$145

0.0% of trade

2 countries · 2 shipments

Fig 4.1 United States is the #1 corridor ($1.6M) — 30 flow arcs from India radiate across 5 continents.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: The world map shows every country colored by how much Indian pioglitazone it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.

§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers

#	Destination	Total USD	Ships	#1 Indian supplier	USD	#2 Indian supplier	USD	#3 Indian supplier	USD
1	United States	$1.6M	43	AUROBINDO PHARMA LTD	$1.2M	MACLEODS PHARMACEUTICALS LTD	$420K	—	—
2	Brazil	$402K	12	AUROBINDO PHARMA LTD	$402K	—	—	—	—
3	Sri Lanka	$89K	9	MICRO LABS LTD	$33K	USV PVT LTD	$30K	THE MADRAS PHARMACEUTICALS	$26K
4	Philippines	$78K	9	MEDLEY PHARMACEUTICALS LTD	$26K	MICRO LABS LTD	$19K	IND SWIFT LABORATORIES LTD	$17K
5	United Arab Emirates	$76K	9	IND SWIFT LABORATORIES LTD	$75K	FALCON TRANSGLOBAL	$81	CLOVERLEAF ECOM PVT LTD	$6
6	Poland	$45K	22	INTAS PHARMACEUTICALS LTD	$45K	—	—	—	—
7	Nigeria	$31K	1	MICRO LABS LTD	$31K	—	—	—	—
8	Croatia	$28K	6	INTAS PHARMACEUTICALS LTD	$28K	—	—	—	—
9	Jamaica	$26K	9	IND SWIFT LTD	$22K	RYVIS PHARMA PVT LTD	$5K	—	—
10	South Africa	$24K	2	MACLEODS PHARMACEUTICALS LTD	$24K	—	—	—	—

Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.

Fig 4.2 Asia leads at 10.6% of USD — but United States is the single largest market.

Region → country treemap

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.

§4.2 Destination concentration

62.7%

#1 country share

United States alone

87.9%

Top 5 share

5 of 30 countries

97.5%

Top 15 share

Long tail of 15 countries = 2.5%

HHI 4219

Destination HHI

Highly concentrated

30

Countries served

Global pharma reach from India

8

Europe countries

Widest regional diversity

Source: TransData Nexus trade data platform

05

PART III — WHO’S IN THIS MARKET

Indian Supplier Rankings & Profiles

25 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence

KEY TAKEAWAY AUROBINDO PHARMA LTD ($1.6M, 62.0% share) and MACLEODS PHARMACEUTICALS LTD ($444.2K) together control 79.4% of India’s 2025-Q4 pioglitazone trade. The top 5 suppliers hold 91.0%. 25 companies shipped at least once.

S FOR SUPPLIERS

Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.

B FOR BUYERS

Find potential Indian pioglitazone suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.

Fig 5.1 AUROBINDO PHARMA LTD leads by $1.1M over MACLEODS PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: RYVIS PHARMA PVT is #18 by value but #10 by volume.

Fig 5.2 INTAS PHARMACEUTICALS LTD also leads by shipment count (55) but ranking shifts for volume-heavy players

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: RYVIS PHARMA PVT moves from #10 by volume to #18 by value — fewer but higher-value shipments.

05

PART III — WHO’S IN THIS MARKET

Supply Landscape — Archetypes & Concentration

How India’s 25 pioglitazone suppliers split into strategic segments

KEY TAKEAWAY 7 suppliers (25%) generate 93.9% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.

Fig 5.3 AUROBINDO PHARMA LTD and MACLEODS PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.

Fig 5.4 25% of suppliers = 93.9% of USD — classic concentration.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.

Product variety — how many formulations each supplier ships

#	Supplier	Dosage forms	Countries	USD
1	AUROBINDO PHARMA LTD	2	2	$1.6M
2	MACLEODS PHARMACEUTICALS LTD	1	2	$444K
3	MICRO LABS LTD	1	4	$107K
4	INTAS PHARMACEUTICALS LTD	1	7	$99K
5	IND SWIFT LABORATORIES LTD	1	3	$92K
6	USV PVT LTD	1	2	$42K
7	THE MADRAS PHARMACEUTICALS	1	2	$31K
8	MEDLEY PHARMACEUTICALS LTD	1	2	$28K
9	IND SWIFT LTD	1	1	$22K
10	LINCOLN PHARMACEUTICALS LTD	1	1	$19K

Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.

05

PART III — WHO’S IN THIS MARKET

Supply Landscape — India Origin Geography & Concentration

Which Indian cities and states are the pioglitazone manufacturing hubs

KEY TAKEAWAY Hyderabad and Baddi together account for $2.0M of India’s 2025-Q4 pioglitazone trade.

Fig 5.5 Hyderabad (1 exporters, $1.6M) and Baddi (1 exporters, $420K) are India’s pioglitazone capitals.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.

§5.1 Supplier concentration metrics

91.0%

Top 5 share

5 of 25 suppliers

96.6%

Top 10 share

10 of 25 suppliers

93.9%

Top 25% share

7 suppliers = 94% USD

HHI 4199

Supplier HHI

Concentrated

25

Total suppliers

shipped Pioglitazone in 2025-Q4

20+ cities

Indian hubs

Hyderabad and Baddi lead

§5.2 Coming next: 9 exporter deep-dive profiles

Each of the top 9 suppliers gets a dedicated 2-page profile with:

6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
Dosage form breakdown — what formulations they ship
Monthly trend — Oct / Nov / Dec trajectory
Trade flow map — supplier → country → importer connections
Buyer portfolio with lock-in analysis

SUPPLIER PROFILES IN THIS REPORT

#1	AUROBINDO PHARMA LTD	$1.6M
#2	MACLEODS PHARMACEUTICALS LTD	$444K
#3	MICRO LABS LTD	$107K
#4	INTAS PHARMACEUTICALS LTD	$99K
#5	IND SWIFT LABORATORIES LTD	$92K
#6	USV PVT LTD	$42K
#7	THE MADRAS PHARMACEUTICALS	$31K
#8	MEDLEY PHARMACEUTICALS LTD	$28K
#9	ARISTO PHARMACEUTICALS PVT LTD	$15K

#1

EXPORTER PROFILE #1 OF 9

AUROBINDO PHARMA LTD

Hyderabad · India’s #1 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$1.6M

62.0% market share

SHIPMENTS

36

avg $44K/ship

COUNTRIES

2

destination markets

BUYERS

8

8 single-sourced

BRANDED

8%

of shipments

DOSAGE FORMS

2

product types

TOP 2 DESTINATIONS

United States is the #1 market at $1.2M (75% of trade), followed by Brazil at $402K. 2 countries served.

#	Country	USD	Ships	Share
1	United States	$1.2M	24	74.7%
2	Brazil	$402K	12	25.3%

MONTHLY TREND

Dec was the strongest month, ending the quarter on a high at $795K.

PRODUCT MIX

Tablet dominates at 100% of trade. Other (0.0%) and others are secondary formulations.

Tablet

100.0%

Other

0.0%

TOP BUYERS · 8/8 LOCKED IN

8 of 8 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
RISING PHARMA HOLDINGS…	United States	$789K	⚠ Locked
AUROLOGISTICS LLC	United States	$229K	⚠ Locked
AUROBINDO PHARMA USA INC	United States	$166K	⚠ Locked
MYRALIS INDUSTRIA FARM…	Brazil	$137K	⚠ Locked
LABORATORIO TEUTO BRAS…	Brazil	$136K	⚠ Locked
BIOLAB SA	Brazil	$96K	⚠ Locked
LABORATORIO GLOBO SA	Brazil	$33K	⚠ Locked
AUROBINDO PHARMA INDUS…	Brazil	$3	⚠ Locked

#1

EXPORTER PROFILE #1 OF 9 — TRADE FLOW MAP

AUROBINDO PHARMA LTD — Supplier → Country → Importer

2 destination countries, top 5 importers per country

Fig 5.P1.3 United States absorbs $1.2M — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 5 importers per destination.

#2

EXPORTER PROFILE #2 OF 9

MACLEODS PHARMACEUTICALS LTD

Baddi · India’s #2 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$444K

17.4% market share

SHIPMENTS

21

avg $21K/ship

COUNTRIES

2

destination markets

BUYERS

3

3 single-sourced

BRANDED

33%

of shipments

DOSAGE FORMS

1

product types

TOP 2 DESTINATIONS

United States is the #1 market at $420K (95% of trade), followed by South Africa at $24K. 2 countries served.

#	Country	USD	Ships	Share
1	United States	$420K	19	94.5%
2	South Africa	$24K	2	5.5%

MONTHLY TREND

Dec was the strongest month, ending the quarter on a high at $194K.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 3/3 LOCKED IN

3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
MACLEODS PHARMA USA INC	United States	$420K	⚠ Locked
MACLEODS PHARMACEUTICA…	South Africa	$24K	⚠ Locked
NORTHSTAR DISTRIBUTION…	United States	$160	⚠ Locked

#2

EXPORTER PROFILE #2 OF 9 — TRADE FLOW MAP

MACLEODS PHARMACEUTICALS LTD — Supplier → Country → Importer

2 destination countries, top 5 importers per country

Fig 5.P2.3 United States absorbs $420K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.

#3

EXPORTER PROFILE #3 OF 9

MICRO LABS LTD

Hosur · India’s #3 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$107K

4.2% market share

SHIPMENTS

7

avg $15K/ship

COUNTRIES

4

destination markets

BUYERS

5

5 single-sourced

BRANDED

43%

of shipments

DOSAGE FORMS

1

product types

TOP 4 DESTINATIONS

Sri Lanka is the #1 market at $33K (31% of trade), followed by Nigeria at $31K. 4 countries served.

#	Country	USD	Ships	Share
1	Sri Lanka	$33K	2	30.7%
2	Nigeria	$31K	1	29.0%
3	United Kingdom	$24K	3	22.5%
4	Philippines	$19K	1	17.8%

MONTHLY TREND

Oct peaked at $63K. Nov was the weakest at $13K.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 5/5 LOCKED IN

5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
MICRO MEGA LANKA (PRIV…	Sri Lanka	$33K	⚠ Locked
MICRO NOVA PHARMACEUTI…	Nigeria	$31K	⚠ Locked
OEP PHILIPPINES INC	Philippines	$19K	⚠ Locked
BROWN AND BURK UK LTD	United Kingdom	$13K	⚠ Locked
BROWN AND BURK UK LIMI…	United Kingdom	$11K	⚠ Locked

#3

EXPORTER PROFILE #3 OF 9 — TRADE FLOW MAP

MICRO LABS LTD — Supplier → Country → Importer

4 destination countries, top 5 importers per country

Fig 5.P3.3 Sri Lanka absorbs $33K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.

#4

EXPORTER PROFILE #4 OF 9

INTAS PHARMACEUTICALS LTD

Ahmedabad · India’s #4 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$99K

3.9% market share

SHIPMENTS

55

avg $2K/ship

COUNTRIES

7

destination markets

BUYERS

5

3 single-sourced

BRANDED

47%

of shipments

DOSAGE FORMS

1

product types

TOP 7 DESTINATIONS

Poland is the #1 market at $45K (45% of trade), followed by Croatia at $28K. 7 countries served.

#	Country	USD	Ships	Share
1	Poland	$45K	22	45.0%
2	Croatia	$28K	6	28.3%
3	Austria	$19K	6	19.0%
4	Greece	$4K	4	4.0%
5	Netherlands	$4K	6	3.6%
6	Spain	$54	7	0.1%
7	United Kingdom	$33	4	0.0%

MONTHLY TREND

Nov peaked at $73K. Dec was the weakest at $277.

PRODUCT MIX

Tablet dominates at 84% of trade. Unknown (15.9%) and others are secondary formulations.

Tablet

84.1%

Unknown

15.9%

TOP BUYERS · 3/3 LOCKED IN

3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
Undisclosed buyer	Poland	$64K	N/A
Undisclosed buyer	Poland	$27K	N/A
ACCORD HEALTHCARE POLS…	Poland	$6K	⚠ Locked
BROCACEF NL:EU HUB	Netherlands	$2K	⚠ Locked
ACCORD HEALTHCARE SING…	Greece	$39	⚠ Locked

#4

EXPORTER PROFILE #4 OF 9 — TRADE FLOW MAP

INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer

5 destination countries, top 5 importers per country

Fig 5.P4.3 Poland absorbs $45K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 3 importers per destination.

#5

EXPORTER PROFILE #5 OF 9

IND SWIFT LABORATORIES LTD

Sas Nagar · India’s #5 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$92K

3.6% market share

SHIPMENTS

5

avg $18K/ship

COUNTRIES

3

destination markets

BUYERS

5

4 single-sourced

BRANDED

80%

of shipments

DOSAGE FORMS

1

product types

TOP 3 DESTINATIONS

United Arab Emirates is the #1 market at $75K (82% of trade), followed by Philippines at $17K. 3 countries served.

#	Country	USD	Ships	Share
1	United Arab Emirates	$75K	2	81.7%
2	Philippines	$17K	2	18.2%
3	Australia	$145	1	0.2%

MONTHLY TREND

Dec was the strongest month, ending the quarter on a high at $76K.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 4/4 LOCKED IN

4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
NEW COUNTRY HEALTHCARE…	United Arab Emirates	$60K	⚠ Locked
LIFE PHARMA FZE	United Arab Emirates	$16K	⚠ Locked
MEDINOVA PHARMACEUTICA…	Philippines	$8K	⚠ Locked
Undisclosed buyer	Philippines	$8K	N/A
APOTEX PTY LTD	Australia	$145	⚠ Locked

#5

EXPORTER PROFILE #5 OF 9 — TRADE FLOW MAP

IND SWIFT LABORATORIES LTD — Supplier → Country → Importer

3 destination countries, top 5 importers per country

Fig 5.P5.3 United Arab Emirates absorbs $75K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.

#6

EXPORTER PROFILE #6 OF 9

USV PVT LTD

Mumbai · India’s #6 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$42K

1.6% market share

SHIPMENTS

6

avg $7K/ship

COUNTRIES

2

destination markets

BUYERS

2

2 single-sourced

BRANDED

100%

of shipments

DOSAGE FORMS

1

product types

TOP 2 DESTINATIONS

Sri Lanka is the #1 market at $30K (71% of trade), followed by Nepal at $12K. 2 countries served.

#	Country	USD	Ships	Share
1	Sri Lanka	$30K	2	70.8%
2	Nepal	$12K	4	29.2%

MONTHLY TREND

Oct peaked at $30K. Nov was the weakest at $2K.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 2/2 LOCKED IN

2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
HEMAS PHARMACEUTICALS …	Sri Lanka	$30K	⚠ Locked
PHARMACHEM PVT LTD	Nepal	$12K	⚠ Locked

#6

EXPORTER PROFILE #6 OF 9 — TRADE FLOW MAP

USV PVT LTD — Supplier → Country → Importer

2 destination countries, top 5 importers per country

Fig 5.P6.3 Sri Lanka absorbs $30K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.

#7

EXPORTER PROFILE #7 OF 9

THE MADRAS PHARMACEUTICALS

Chennai · India’s #7 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$31K

1.2% market share

SHIPMENTS

6

avg $5K/ship

COUNTRIES

2

destination markets

BUYERS

4

3 single-sourced

BRANDED

100%

of shipments

DOSAGE FORMS

1

product types

TOP 2 DESTINATIONS

Sri Lanka is the #1 market at $26K (84% of trade), followed by Ghana at $5K. 2 countries served.

#	Country	USD	Ships	Share
1	Sri Lanka	$26K	5	84.0%
2	Ghana	$5K	1	16.0%

MONTHLY TREND

Dec was the strongest month, ending the quarter on a high at $21K.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 3/3 LOCKED IN

3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
STATE PHARMACEUTICALS …	Sri Lanka	$16K	⚠ Locked
M/S.PHARMA ASSOCIATES	Sri Lanka	$5K	⚠ Locked
Undisclosed buyer	Sri Lanka	$5K	N/A
LYMENS MEDICAL SUPPLIE…	Ghana	$5K	⚠ Locked

#7

EXPORTER PROFILE #7 OF 9 — TRADE FLOW MAP

THE MADRAS PHARMACEUTICALS — Supplier → Country → Importer

2 destination countries, top 5 importers per country

Fig 5.P7.3 Sri Lanka absorbs $26K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 3 importers per destination.

#8

EXPORTER PROFILE #8 OF 9

MEDLEY PHARMACEUTICALS LTD

Mumbai · India’s #8 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$28K

1.1% market share

SHIPMENTS

5

avg $6K/ship

COUNTRIES

2

destination markets

BUYERS

3

1 single-sourced

BRANDED

40%

of shipments

DOSAGE FORMS

1

product types

TOP 2 DESTINATIONS

Philippines is the #1 market at $26K (95% of trade), followed by Maldives at $2K. 2 countries served.

#	Country	USD	Ships	Share
1	Philippines	$26K	3	94.5%
2	Maldives	$2K	2	5.5%

MONTHLY TREND

Nov peaked at $26K. Oct was the weakest at $0.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 1/2 LOCKED IN

1 of 2 buyers source exclusively from this supplier — moderate lock-in, some buyers diversify.

Buyer	Country	USD	Status
AMBICA INTERNATIONAL C…	Philippines	$15K	2 sup.
Undisclosed buyer	Philippines	$11K	N/A
ADK PHARMACEUTICAL COM…	Maldives	$2K	⚠ Locked

#8

EXPORTER PROFILE #8 OF 9 — TRADE FLOW MAP

MEDLEY PHARMACEUTICALS LTD — Supplier → Country → Importer

2 destination countries, top 5 importers per country

Fig 5.P8.3 Philippines absorbs $26K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.

#12

EXPORTER PROFILE #9 OF 9

ARISTO PHARMACEUTICALS PVT LTD

Raisen · India’s #12 pioglitazone supplier by USD · 2025-Q4

2025-Q4 USD

$15K

0.6% market share

SHIPMENTS

6

avg $3K/ship

COUNTRIES

3

destination markets

BUYERS

3

3 single-sourced

BRANDED

100%

of shipments

DOSAGE FORMS

1

product types

TOP 3 DESTINATIONS

Tanzania is the #1 market at $10K (65% of trade), followed by Chile at $4K. 3 countries served.

#	Country	USD	Ships	Share
1	Tanzania	$10K	2	64.8%
2	Chile	$4K	2	27.3%
3	Nepal	$1K	2	7.9%

MONTHLY TREND

Dec was the strongest month, ending the quarter on a high at $10K.

PRODUCT MIX

Tablet dominates at 100% of trade.

Tablet

100.0%

TOP BUYERS · 3/3 LOCKED IN

3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
PLANET PHARMACEUTICAL …	Tanzania	$10K	⚠ Locked
SOUTH AMERICAN EXPRESS…	Chile	$4K	⚠ Locked
UNIQUE TRADE LINK PVT …	Nepal	$1K	⚠ Locked

#12

EXPORTER PROFILE #9 OF 9 — TRADE FLOW MAP

ARISTO PHARMACEUTICALS PVT LTD — Supplier → Country → Importer

3 destination countries, top 5 importers per country

Fig 5.P9.3 Tanzania absorbs $10K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.

06

PART III — WHO’S IN THIS MARKET

Global Buyer Rankings & Intelligence

45 importers across 30 countries — who is buying Indian pioglitazone and how much

KEY TAKEAWAY The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 92.7% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.

S FOR SUPPLIERS

Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).

B FOR BUYERS

See where you rank among global importers of Indian pioglitazone. Compare your USD and shipment count against peers in your country and dosage segment.

Fig 6.1 RISING PHARMA HOLDINGS INC is the #1 importer at $789K (30.8%) — top 25 by trade value

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one global importer ranked by USD.

Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Same 25 importers re-ranked by shipment count.

§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?

91%

Single-source

41 buyers rely on exactly 1 Indian supplier

4%

Dual-source

2 buyers use 2 Indian suppliers

2%

Multi-source (3–4)

1 buyers diversified across 3–4

2%

Broad-source (5+)

1 buyers with 5+ Indian suppliers

06

PART III — WHO’S IN THIS MARKET

Single-Source Buyers & Price Benchmark

Lock-in opportunities grouped by country + where each buyer sits on the price spectrum

KEY TAKEAWAY These importers source pioglitazone from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.

S FOR SUPPLIERS

This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.

B FOR BUYERS

If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.

§6.2 Single-source lock-in by country

United States 5 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
RISING PHARMA HOLDINGS…	AUROBINDO PHARMA LTD	$789K	$0.022	Tablet
MACLEODS PHARMA USA INC	MACLEODS PHARMACEUTI…	$420K	$0.021	Tablet
AUROLOGISTICS LLC	AUROBINDO PHARMA LTD	$229K	$0.026	Tablet
AUROBINDO PHARMA USA INC	AUROBINDO PHARMA LTD	$166K	$0.023	Tablet
NORTHSTAR DISTRIBUTION…	MACLEODS PHARMACEUTI…	$159.817	$0.0003	Tablet

Brazil 5 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
MYRALIS INDUSTRIA FARM…	AUROBINDO PHARMA LTD	$137K	$0.040	Tablet
LABORATORIO TEUTO BRAS…	AUROBINDO PHARMA LTD	$136K	$0.039	Tablet
BIOLAB SA	AUROBINDO PHARMA LTD	$96K	$0.033	Tablet
LABORATORIO GLOBO SA	AUROBINDO PHARMA LTD	$33K	$0.036	Tablet
AUROBINDO PHARMA INDUS…	AUROBINDO PHARMA LTD	$2.831	$2.831	Other

Sri Lanka 4 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
MICRO MEGA LANKA (PRIV…	MICRO LABS LTD	$33K	$3.888	Tablet
HEMAS PHARMACEUTICALS …	USV PVT LTD	$30K	$4.598	Tablet
STATE PHARMACEUTICALS …	THE MADRAS PHARMACEU…	$16K	$0.778	Tablet
M/S.PHARMA ASSOCIATES	THE MADRAS PHARMACEU…	$5K	$0.457	Tablet

United Arab Emirates 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
NEW COUNTRY HEALTHCARE…	IND SWIFT LABORATORI…	$60K	$0.146	Tablet
LIFE PHARMA FZE	IND SWIFT LABORATORI…	$16K	$0.080	Tablet

Jamaica 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
INDIES PHARMA JAMAICA …	IND SWIFT LTD	$22K	$0.053	Tablet
RPPL	RYVIS PHARMA PVT LTD	$5K	$0.446	Tablet

§6.3 Price positioning — top 25 importers

#	Importer	Country	USD	$/ship	Tier
1	RISING PHARMA HOLDIN…	United States	$789K	$56K	Premium
2	MACLEODS PHARMA USA …	United States	$420K	$23K	Mid
3	AUROLOGISTICS LLC	United States	$229K	$46K	Premium
4	AUROBINDO PHARMA USA…	United States	$166K	$33K	Mid
5	MYRALIS INDUSTRIA FA…	Brazil	$137K	$46K	Premium
6	LABORATORIO TEUTO BR…	Brazil	$136K	$34K	Mid
7	BIOLAB SA	Brazil	$96K	$32K	Mid
8	NEW COUNTRY HEALTHCA…	United Arab Emirates	$60K	$60K	Premium
9	LABORATORIO GLOBO SA	Brazil	$33K	$33K	Mid
10	MICRO MEGA LANKA (PR…	Sri Lanka	$33K	$16K	Mid
11	MICRO NOVA PHARMACEU…	Nigeria	$31K	$31K	Mid
12	HEMAS PHARMACEUTICAL…	Sri Lanka	$30K	$15K	Budget
13	MACLEODS PHARMACEUTI…	South Africa	$24K	$12K	Budget
14	INDIES PHARMA JAMAIC…	Jamaica	$22K	$5K	Budget
15	AMBICA INTERNATIONAL…	Philippines	$20K	$7K	Budget
16	J.P.CCANADA CANADACA…	Canada	$19K	$6K	Budget
17	OEP PHILIPPINES INC	Philippines	$19K	$19K	Mid
18	AXIERTA CAL. EMETE R…	Peru	$16K	$8K	Budget
19	LIFE PHARMA FZE	United Arab Emirates	$16K	$16K	Mid
20	STATE PHARMACEUTICAL…	Sri Lanka	$16K	$16K	Mid
21	MYLAN HUNGARY KFT	Hungary	$14K	$14K	Budget
22	BROWN AND BURK UK LTD	United Kingdom	$13K	$7K	Budget
23	PHARMACHEM PVT LTD	Nepal	$12K	$3K	Budget
24	BROWN AND BURK UK LI…	United Kingdom	$11K	$11K	Budget
25	PLANET PHARMACEUTICA…	Tanzania	$10K	$5K	Budget

06

PART III — WHO’S IN THIS MARKET

Market Relationship Map

The top 20 × 20 supplier ↔ buyer network as a circular flow diagram

Fig 6.3 AUROBINDO PHARMA LTD → RISING PHARMA HOLDINGS INC is the strongest relationship.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.

07

PART IV — MARKET BEHAVIOR

Price Benchmarks & Analysis

How Indian pioglitazone prices vary by supplier, country and dosage form

KEY TAKEAWAY Pioglitazone prices span 1125285× ($0.0000 → $7.62). The coefficient of variation is 2.61. Dosage form, not destination, is the primary price driver.

S FOR SUPPLIERS

Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.

B FOR BUYERS

Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.

§7.1 Price distribution · Table 7.1

Statistic	Value	Interpretation
Min	$0.0000	Lowest observed unit price
P5	$0.0003	5th percentile
P25	$0.017	25th percentile (Q1)
Median	$0.024	50th percentile (Q2)
P75	$0.295	75th percentile (Q3)
P95	$2.86	95th percentile
Max	$7.62	Highest observed unit price
Mean	$0.462	Arithmetic average
CV	261%	Coefficient of variation (std/mean)

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

Fig 7.1 LINCOLN PHARMACEUTICALS LTD prices at $5.59/unit vs market median $0.024.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).

COMMODITY KINGS

high volume · low unit price

Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. AUROBINDO PHARMA LTD Sourcing: best for cost-driven procurement.

BULK LEADERS

high volume · premium price

Branded-generic leaders, above-median pricing. e.g. MICRO LABS LTD Sourcing: hardest to displace; compete on relationship.

LONG-TAIL

low volume · low unit price

Spot/opportunistic players. e.g. KWALITY PHARMACEUTICALS LTD Sourcing: first to approach for new tenders.

PREMIUM NICHE

low volume · premium price

Sterile injectables and infusions. Hospital-grade. e.g. LINCOLN PHARMACEUTICALS LTD Sourcing: expect 10× price vs tablet.

07

PART IV — MARKET BEHAVIOR

Price Benchmarks & Analysis

Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage

KEY TAKEAWAY Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.

§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices

↑ TOP 10 HIGHEST USD/UNIT

Date	Exporter	Country	Dosage	Qty	USD	$/unit	Why
Nov 2025	SANITAS MEDTECH …	Singapore	Tablet	60	$844.71	$14.08	Specialty / small-batch
Oct 2025	MICRO LABS LTD	Sri Lanka	Tablet	4K	$33K	$7.62	Specialty / small-batch
Oct 2025	LINCOLN PHARMACE…	Canada	Tablet	864	$6K	$7.39	Specialty / small-batch
Dec 2025	MEDLEY PHARMACEU…	Maldives	Tablet	83	$492.94	$5.94	Specialty / small-batch
Oct 2025	LINCOLN PHARMACE…	Canada	Tablet	1K	$7K	$4.89	Specialty / small-batch
Oct 2025	USV PVT LTD	Sri Lanka	Tablet	3K	$15K	$4.62	Specialty / small-batch
Oct 2025	USV PVT LTD	Sri Lanka	Tablet	3K	$15K	$4.57	Specialty / small-batch
Oct 2025	LINCOLN PHARMACE…	Canada	Tablet	1K	$6K	$4.48	Specialty / small-batch
Oct 2025	MICRO LABS LTD	Philippines	Tablet	6K	$19K	$3.33	Specialty / small-batch
Dec 2025	MEDLEY PHARMACEU…	Maldives	Tablet	333	$1K	$3.09	Specialty / small-batch

↓ TOP 10 LOWEST USD/UNIT

Date	Exporter	Country	Dosage	Qty	USD	$/unit	Why
Dec 2025	RYVIS PHARMA PVT…	Jamaica	Tablet	5K	$23.30	$0.0047	Bulk generic tablet
Dec 2025	INTAS PHARMACEUT…	Spain	Tablet	720	$8.25	$0.011	Small sample / trial shipment
Dec 2025	AUROBINDO PHARMA…	United States	Tablet	495K	$7K	$0.014
Dec 2025	AUROBINDO PHARMA…	United States	Tablet	5.3M	$73K	$0.014	Bulk volume discount
Nov 2025	INTAS PHARMACEUT…	Spain	Tablet	560	$7.93	$0.014	Small sample / trial shipment
Nov 2025	INTAS PHARMACEUT…	Spain	Tablet	560	$7.93	$0.014	Small sample / trial shipment
Nov 2025	INTAS PHARMACEUT…	Spain	Tablet	480	$6.92	$0.014	Small sample / trial shipment
Nov 2025	INTAS PHARMACEUT…	Spain	Tablet	480	$6.92	$0.014	Small sample / trial shipment
Oct 2025	AUROBINDO PHARMA…	United States	Tablet	900K	$13K	$0.015
Nov 2025	INTAS PHARMACEUT…	United Kingdom	Tablet	504	$7.41	$0.015	Small sample / trial shipment

§7.3 Procurement cheat sheet — median USD/unit by country × dosage

Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.

NEGOTIATION RANGE

Use each cell value as the anchor price. Typical dynamics:

Budget buyer: anchor − 10–15% (floor = cost + freight)
Mid-market: anchor ± 5–10%
Premium/tender: anchor + 10–25% (regulated, quality premium)
Injection/infusion: always 4–10× the tablet price

KEY TAKEAWAYS

Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment

08

PART IV — MARKET BEHAVIOR

Shipping Ports & Trade Routes

Which Indian ports ship pioglitazone, which global ports receive it, and which corridors are high-value vs bulk

KEY TAKEAWAY Pioglitazone leaves India through 17+ ports. The top 5 (HYDERABAD ICD, CHAWAPAYAL ICD, NHAVA SHEVA SEA (JNPT)) handle 87.7% of total USD. ICD moves 31% of shipments.

S FOR SUPPLIERS

Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.

B FOR BUYERS

Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.

Fig 8.1 HYDERABAD ICD handles $1.5M — top 17 Indian origin ports by trade value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.

Fig 8.2 NEWARK is the #1 global destination port — top 25 by USD value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.

§8.1 Reference transit times for key India → global corridors

Route	Mode	Transit time	Notes
NHAVA SHEVA SEA (JNPT) → US East Coast	Sea	22–28 days	Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)	Sea	18–24 days	Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK	Air	3–5 days	Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam	Sea	20–26 days	Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow	Air	2–4 days	Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)	Sea	7–12 days	Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)	Road	1–2 days	Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)	Sea	14–20 days	Direct or via Colombo hub

Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.

08

PART IV — MARKET BEHAVIOR

Shipping Ports & Trade Routes

Trade corridors — origin port to mode of transport to destination region

KEY TAKEAWAY ICD dominates at 31% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.

ICD

$2.0M

76.2% of USD · 30.8% of ships

AIR

$348K

13.6% of USD · 32.4% of ships

SEA

$247K

9.6% of USD · 33.5% of ships

ROAD

$14K

0.5% of USD · 3.3% of ships

Fig 8.3 The dominant corridor is HYDERABAD ICD → Sea → N. America ($1.2M).

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.

09

PART V — ACTION

Strategic Opportunities & Action Plan

Market concentration, supply-chain risk, and the dependency patterns that signal where to act

KEY TAKEAWAY Poland is the most concentrated destination (HHI 10000, 1 suppliers). Philippines is the most competitive (HHI 2434).

S FOR SUPPLIERS

The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.

B FOR BUYERS

The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.

Fig 9.1 Poland (HHI 10,000) is the most concentrated — Philippines (HHI 2,434) is the most competitive.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 19 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.

§9.1 Single-source dependencies

Buyer	Country	Sole supplier	USD	Ships	Risk
RISING PHARMA HOLDIN…	United States	AUROBINDO PHARMA…	$789K	14	CRITICAL
MACLEODS PHARMA USA …	United States	MACLEODS PHARMAC…	$420K	18	HIGH
AUROLOGISTICS LLC	United States	AUROBINDO PHARMA…	$229K	5	HIGH
AUROBINDO PHARMA USA…	United States	AUROBINDO PHARMA…	$166K	5	HIGH
MYRALIS INDUSTRIA FA…	Brazil	AUROBINDO PHARMA…	$137K	3	HIGH
LABORATORIO TEUTO BR…	Brazil	AUROBINDO PHARMA…	$136K	4	HIGH
BIOLAB SA	Brazil	AUROBINDO PHARMA…	$96K	3	MEDIUM
NEW COUNTRY HEALTHCA…	United Arab Emirates	IND SWIFT LABORA…	$60K	1	MEDIUM

Conclusion: 41 buyers depend on exactly one Indian supplier, representing $2.4M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.

§9.2 Multi-source resilience

Buyer	Country	Suppliers	USD	Dominant	Resilience

Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.

09

PART V — ACTION

Strategic Opportunities & Action Plan

Market entry playbook and risk landscape by destination country

KEY TAKEAWAY 15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).

§9.3 Sourcing recommendations · Table 9.1

Country	Tier	Lead	Price	Risk	Entry approach
United States	Tier 3 (emerging)	14–28 days (sea)	$0.01–$0.10/unit	LOW	First-mover advantage
Brazil	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
Sri Lanka	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
Philippines	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
United Arab Emirates	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
Poland	Tier 3 (emerging)	3–5 days (air)	$0.01–$0.10/unit	LOW	First-mover advantage
Nigeria	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Croatia	Tier 3 (emerging)	3–5 days (air)	$0.01–$0.10/unit	LOW	First-mover advantage
Jamaica	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
South Africa	Tier 3 (emerging)	14–28 days (sea)	$0.01–$0.10/unit	LOW	First-mover advantage
United Kingdom	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
Canada	Tier 3 (emerging)	14–28 days (sea)	$1–$10/unit	LOW	First-mover advantage
Austria	Tier 3 (emerging)	3–5 days (air)	$0.01–$0.10/unit	LOW	First-mover advantage
Peru	Tier 3 (emerging)	14–28 days (sea)	$0.01–$0.10/unit	LOW	First-mover advantage
Hungary	Tier 3 (emerging)	3–5 days (air)	$0.01–$0.10/unit	LOW	First-mover advantage

For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.

Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.

09

PART V — ACTION

Action Plan & Easy-Entry Markets

12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers

KEY TAKEAWAY Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.

S

FOR SUPPLIERS

ID	Action	Timing	Impact
A1	Pitch top single-source buyer in United States	This Q	HIGH
A2	Offer alternative to top multi-source buyer	This Q	HIGH
A3	Audit Poland lock-ins (HHI 10000)	This Q	MED
A5	Enter United States (2 suppliers)	This Q	HIGH
A6	Enter Brazil (1 suppliers)	This Q	MED
A8	Build Brazil distribution	6–12m	HIGH
A9	Bundle injection/infusion catalog for premium markets	6–12m	MED

B

FOR BUYERS

ID	Action	Timing	Impact
A4	Monitor rising exporters (climbers)	This Q	MED
A7	Register for United States tenders	6–12m	HIGH
A10	Track quarterly HHI shifts across key destinations	This Q	LOW
A11	Map competitor buyer portfolios quarterly	This Q	MED
A12	Qualify second source for single-source buyers	This Q	MED

§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers

#	Country	Region	Suppliers	Q4 USD	Growth	Barrier	Why this is easy
1	United States	Other	2	$1.6M	+2.2%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
2	Brazil	Other	1	$402K	+111.3%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
3	Nepal	Asia	2	$14K	+884.4%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
4	Sri Lanka	Asia	3	$89K	-75.1%	LOW	Low competition (3 suppliers), accessible market
5	Philippines	Asia	5	$78K	-84.4%	LOW	Low competition (5 suppliers), accessible market
6	United Arab Emirates	Other	3	$76K	0%	LOW	Low competition (3 suppliers), accessible market
7	Poland	Other	1	$45K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
8	Nigeria	Africa	1	$31K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
9	Croatia	Other	1	$28K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
10	Jamaica	Other	2	$26K	-93.3%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
11	South Africa	Africa	1	$24K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
12	United Kingdom	Other	2	$24K	-99.8%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
13	Canada	Other	1	$19K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
14	Austria	Other	1	$19K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
15	Peru	Other	1	$16K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry

This report covers 182 2025-Q4 Pioglitazone shipments. TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020. → transdatanexus.com/pharmaceutical/pioglitazone

10

PART VI — EVIDENCE REGISTER

Comprehensive Shipment Records by Region

Authoritative source behind all analytics in this report — every shipment appears exactly once

KEY TAKEAWAY This section contains every one of the 182 2025-Q4 pioglitazone shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.

S FOR SUPPLIERS

Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.

B FOR BUYERS

Jump to your country to see every Indian pioglitazone shipment that arrived in 2025-Q4: supplier, price, dosage, port.

§10.1 Global totals

SHIPMENTS

182

across all regions

TOTAL USD

$2.56M

2025-Q4 FOB value

UNITS

92.4M

tablets, capsules, etc.

SUPPLIERS

25

Indian exporters

BUYERS

45

global importers

COUNTRIES

30

destinations

§10.2 Regional breakdown

Africa

$73K

2.8%

5 ctry · 8 ships

Asia

$271K

10.6%

8 ctry · 40 ships

Europe

$137K

5.4%

8 ctry · 59 ships

Americas

$2.08M

81.2%

7 ctry · 73 ships

Oceania

$145.41

0.0%

2 ctry · 2 ships

§10.3 Key insights from the data

🌍

Africa is the largest region at $73K (2.8%), spanning 5 countries.

🏢

25 Indian suppliers shipped to 45 buyers across 30 countries — average shipment value $14K.

📄

Top 0 markets: .

🔍

Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.

§10.4 How to read a country page

1

6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.

2

4 mini-lists — top exporters, importers, dosages, monthly trend.

3

Shipment register — every row grouped by exporter. No row is duplicated or omitted.

10

PART VI — DRILL-DOWN · AFRICA

Region: Africa

5 countries · 8 shipments · $73K · 6 Indian suppliers · 6 buyers

SHIPMENTS

8

USD

$73K

COUNTRIES

5

SUPPLIERS

6

BUYERS

6

HHI

3,185

concentrated

Top 5 destination countries in Africa

1

Nigeria (42.6%)

$31K

2

South Africa (33.5%)

$24K

3

Tanzania (13.7%)

$10K

4

Ghana (10.2%)

$7K

5

Zambia (0.0%)

$0.610

Top 6 Indian suppliers into Africa

1

MICRO LABS LTD

$31K

2

MACLEODS PHARMACEUTICALS LTD

$24K

3

ARISTO PHARMACEUTICALS PVT LTD

$10K

4

THE MADRAS PHARMACEUTICALS

$5K

5

MASCOT HEALTH SERIES PVT LTD

$2K

6

MEDICOS LIFESCIENCES

$0.610

Top 6 Africa importers

1

MICRO NOVA PHARMACEUTICALS IND · Nigeria

$31K

2

MACLEODS PHARMACEUTICALS SA · South Africa

$24K

3

PLANET PHARMACEUTICAL LTD · Tanzania

$10K

4

LYMENS MEDICAL SUPPLIES LTD · Ghana

$5K

5

LYMENS MEDICAL SUPPLY LTD · Ghana

$2K

6

LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia

$0.610

Top 1 dosage forms

1

Tablet

$73K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	2	$24K	$12K
Nov	2	$2K	$1K
Dec	4	$46K	$11K

Shipment register · 8 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — MICRO LABS LTD · 1 shipments · $31K
1	Dec 2025	MICRO NOVA PHARMACEUTICALS IND	Nigeria	Tablet	15.9K	PCS	$1.94	$31K	BANGALORE AIR	LAGOS	AIR
SUPPLIER #2 — MACLEODS PHARMACEUTICALS LTD · 2 shipments · $24K
2	Oct 2025	MACLEODS PHARMACEUTICALS SA	South Africa	Tablet	540.0K	NOS	$0.023	$13K	NHAVA SHEVA SEA (JNPT)	Durban	SEA
3	Oct 2025	MACLEODS PHARMACEUTICALS SA	South Africa	Tablet	297.0K	NOS	$0.039	$12K	NHAVA SHEVA SEA (JNPT)	Durban	SEA
SUPPLIER #3 — ARISTO PHARMACEUTICALS PVT LTD · 2 shipments · $10K
4	Dec 2025	PLANET PHARMACEUTICAL LTD	Tanzania	Tablet	513.0K	TBS	$0.018	$9K	MUMBAI AIR (SAHAR)	DAR ES SALAM (DARESS	AIR
5	Dec 2025	PLANET PHARMACEUTICAL LTD	Tanzania	Tablet	51.3K	TBS	$0.018	$903.75	MUMBAI AIR (SAHAR)	DAR ES SALAM (DARESS	AIR
SUPPLIER #4 — THE MADRAS PHARMACEUTICALS · 1 shipments · $5K
6	Dec 2025	LYMENS MEDICAL SUPPLIES LTD	Ghana	Tablet	9.9K	PCS	$0.502	$5K	CHENNAI SEA	Tema	SEA
SUPPLIER #5 — MASCOT HEALTH SERIES PVT LTD · 1 shipments · $2K
7	Nov 2025	LYMENS MEDICAL SUPPLY LTD	Ghana	Tablet	10.1K	NOS	$0.240	$2K	NHAVA SHEVA SEA (JNPT)	Tema	SEA
SUPPLIER #6 — MEDICOS LIFESCIENCES · 1 shipments · $0.610
8	Nov 2025	LUSAKA PHARMA CHEM SUPPLIES LTD	Zambia	Tablet	10	NOS	$0.061	$0.610	AHMEDABAD AIR	LUSAKA	AIR

10

PART VI — DRILL-DOWN · ASIA

Region: Asia

8 countries · 40 shipments · $271K · 13 Indian suppliers · 16 buyers

SHIPMENTS

40

USD

$271K

COUNTRIES

8

SUPPLIERS

13

BUYERS

16

HHI

2,011

moderate

Top 8 destination countries in Asia

1

Sri Lanka (32.7%)

$89K

2

Philippines (28.9%)

$78K

3

United Arab Emirates (27.9%)

$76K

4

Nepal (5.0%)

$14K

5

Myanmar (4.5%)

$12K

6

Maldives (0.6%)

$2K

7

Singapore (0.3%)

$844.71

8

Iraq (0.0%)

$94.94

Top 13 Indian suppliers into Asia

1

IND SWIFT LABORATORIES LTD

$92K

2

MICRO LABS LTD

$52K

3

USV PVT LTD

$42K

4

MEDLEY PHARMACEUTICALS LTD

$28K

5

THE MADRAS PHARMACEUTICALS

$26K

6

SAGA LIFESCIENCES LTD

$12K

7

UMEDICA LABORATORIES PVT LTD

$11K

8

UNOSOURCE PHARMA LTD

$5K

9

ARISTO PHARMACEUTICALS PVT LTD

$1K

10

SANITAS MEDTECH INSTITUTE PVT LTD

$844.71

11

ZEAL PHARMA

$94.94

12

FALCON TRANSGLOBAL

$80.69

13

CLOVERLEAF ECOM PVT LTD

$5.59

Top 14 Asia importers

1

NEW COUNTRY HEALTHCARE LLC · United Arab Emirates

$60K

2

MICRO MEGA LANKA (PRIVATE) LTD · Sri Lanka

$33K

3

HEMAS PHARMACEUTICALS (PVT) LTD · Sri Lanka

$30K

4

AMBICA INTERNATIONAL CORP · Philippines

$20K

5

OEP PHILIPPINES INC · Philippines

$19K

6

LIFE PHARMA FZE · United Arab Emirates

$16K

7

STATE PHARMACEUTICALS CORP · Sri Lanka

$16K

8

PHARMACHEM PVT LTD · Nepal

$12K

9

MEDINOVA PHARMACEUTICAL INC · Philippines

$8K

10

M/S.PHARMA ASSOCIATES · Sri Lanka

$5K

11

ADK PHARMACEUTICAL COMPANY PVT LTD · Maldives

$2K

12

UNIQUE TRADE LINK PVT LTD · Nepal

$1K

13

SUCCESS INTER LINK PTE LTD · Singapore

$844.71

14

EMIRATES POST GROUP · United Arab Emirates

$86.28

Top 3 dosage forms

1

Tablet

$271K

2

Other

$12.13

3

Unknown

$5.59

Monthly trend

Month	Ships	USD	Avg/ship
Oct	8	$94K	$12K
Nov	16	$57K	$4K
Dec	16	$120K	$7K

Shipment register · 40 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — IND SWIFT LABORATORIES LTD · 4 shipments · $92K
1	Nov 2025	MEDINOVA PHARMACEUTICAL INC	Philippines	Tablet	411.4K	NOS	$0.020	$8K	DELHI AIR	MANILA	AIR
2	Nov 2025	UNKNOWN BUYER	Philippines	Tablet	411.4K	NOS	$0.020	$8K	DELHI AIR	MANILA	AIR
3	Dec 2025	NEW COUNTRY HEALTHCARE LLC	United Arab Emirates	Tablet	409.5K	NOS	$0.146	$60K	DELHI AIR	DUBAI	AIR
4	Dec 2025	LIFE PHARMA FZE	United Arab Emirates	Tablet	197.4K	NOS	$0.080	$16K	NHAVA SHEVA SEA (JNPT)	Jebel Ali	SEA
SUPPLIER #2 — MICRO LABS LTD · 3 shipments · $52K
5	Oct 2025	OEP PHILIPPINES INC	Philippines	Tablet	5.7K	PCS	$3.33	$19K	HOSUR ICD TAMILNADU	PHMNL	ICD
6	Oct 2025	MICRO MEGA LANKA (PRIVATE) LTD	Sri Lanka	Tablet	4.3K	PCS	$7.62	$33K	HOSUR ICD TAMILNADU	Colombo	ICD
7	Oct 2025	MICRO MEGA LANKA (PRIVATE) LTD	Sri Lanka	Tablet	4.1K	PCS	$0.0001	$0.411	HOSUR ICD TAMILNADU	Colombo	ICD
SUPPLIER #3 — USV PVT LTD · 6 shipments · $42K
8	Oct 2025	HEMAS PHARMACEUTICALS (PVT) LTD	Sri Lanka	Tablet	3.2K	NOS	$4.62	$15K	NHAVA SHEVA SEA (JNPT)	Colombo	SEA
9	Oct 2025	HEMAS PHARMACEUTICALS (PVT) LTD	Sri Lanka	Tablet	3.2K	NOS	$4.57	$15K	NHAVA SHEVA SEA (JNPT)	Colombo	SEA
10	Nov 2025	PHARMACHEM PVT LTD	Nepal	Tablet	2.5K	NOS	$0.064	$160.45	RAXAUL	Birgunj	ROAD
11	Nov 2025	PHARMACHEM PVT LTD	Nepal	Tablet	6.6K	NOS	$0.322	$2K	RAXAUL	Birgunj	ROAD
12	Dec 2025	PHARMACHEM PVT LTD	Nepal	Tablet	16.4K	NOS	$0.323	$5K	RAXAUL	BIRGUNJ	ROAD
13	Dec 2025	PHARMACHEM PVT LTD	Nepal	Tablet	8.8K	NOS	$0.536	$5K	RAXAUL	BIRGUNJ	ROAD
SUPPLIER #4 — MEDLEY PHARMACEUTICALS LTD · 5 shipments · $28K
14	Nov 2025	AMBICA INTERNATIONAL CORP	Philippines	Tablet	19.3K	NOS	$0.589	$11K	MUMBAI AIR (SAHAR)	MANILA	AIR
15	Nov 2025	UNKNOWN BUYER	Philippines	Tablet	19.3K	NOS	$0.589	$11K	MUMBAI AIR (SAHAR)	MANILA	AIR
16	Nov 2025	AMBICA INTERNATIONAL CORP	Philippines	Tablet	1.9K	NOS	$1.86	$4K	MUMBAI AIR (SAHAR)	MANILA	AIR
17	Dec 2025	ADK PHARMACEUTICAL COMPANY PVT LTD	Maldives	Tablet	333	NOS	$3.09	$1K	MUMBAI AIR (SAHAR)	MALE	AIR
18	Dec 2025	ADK PHARMACEUTICAL COMPANY PVT LTD	Maldives	Tablet	83	NOS	$5.94	$492.94	MUMBAI AIR (SAHAR)	MALE	AIR
SUPPLIER #5 — THE MADRAS PHARMACEUTICALS · 5 shipments · $26K
19	Nov 2025	M/S.PHARMA ASSOCIATES	Sri Lanka	Tablet	5.8K	PCS	$0.397	$2K	CHENNAI SEA	Colombo	SEA
20	Nov 2025	M/S.PHARMA ASSOCIATES	Sri Lanka	Tablet	5.8K	PCS	$0.516	$3K	CHENNAI SEA	Colombo	SEA
21	Nov 2025	UNKNOWN BUYER	Sri Lanka	Tablet	5.8K	PCS	$0.397	$2K	CHENNAI SEA	Colombo	SEA
22	Nov 2025	UNKNOWN BUYER	Sri Lanka	Tablet	5.8K	PCS	$0.516	$3K	CHENNAI SEA	Colombo	SEA
23	Dec 2025	STATE PHARMACEUTICALS CORP	Sri Lanka	Tablet	20.0K	PCS	$0.778	$16K	CHENNAI SEA	Colombo	SEA
SUPPLIER #6 — SAGA LIFESCIENCES LTD · 2 shipments · $12K
24	Dec 2025	UNLISTED BUYER	Myanmar	Tablet	4.6K	NOS	$1.17	$5K	AHMEDABAD AIR	YANGON	AIR
25	Dec 2025	UNLISTED BUYER	Myanmar	Tablet	4.8K	NOS	$1.44	$7K	AHMEDABAD AIR	YANGON	AIR
SUPPLIER #7 — UMEDICA LABORATORIES PVT LTD · 2 shipments · $11K
26	Oct 2025	UNLISTED BUYER	Philippines	Tablet	9.4K	NOS	$0.476	$4K	NHAVA SHEVA SEA (JNPT)	Manila North Harbor	SEA
27	Oct 2025	UNLISTED BUYER	Philippines	Tablet	9.5K	NOS	$0.714	$7K	NHAVA SHEVA SEA (JNPT)	Manila North Harbor	SEA
SUPPLIER #8 — UNOSOURCE PHARMA LTD · 1 shipments · $5K
28	Dec 2025	AMBICA INTERNATIONAL CORP	Philippines	Tablet	3.0K	NOS	$1.59	$5K	DELHI AIR	MANILA	AIR
SUPPLIER #9 — ARISTO PHARMACEUTICALS PVT LTD · 2 shipments · $1K
29	Oct 2025	UNIQUE TRADE LINK PVT LTD	Nepal	Tablet	2.1K	NOS	$0.484	$1K	RAXAUL	BIRGUNJ	ROAD
30	Nov 2025	UNIQUE TRADE LINK PVT LTD	Nepal	Tablet	420	NOS	$0.484	$203.36	RAXAUL	Birgunj	ROAD
SUPPLIER #10 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $844.71
31	Nov 2025	SUCCESS INTER LINK PTE LTD	Singapore	Tablet	60	NOS	$14.08	$844.71	MUMBAI AIR (SAHAR)	SINGAPORE	AIR
SUPPLIER #11 — ZEAL PHARMA · 2 shipments · $94.94
32	Dec 2025	UNLISTED BUYER	Iraq	Tablet	500	NOS	$0.095	$47.47	AHMEDABAD AIR	BAGDAD, METROPOLITAN	AIR
33	Dec 2025	UNLISTED BUYER	Iraq	Tablet	500	NOS	$0.095	$47.47	AHMEDABAD AIR	BAGDAD, METROPOLITAN	AIR
SUPPLIER #12 — FALCON TRANSGLOBAL · 6 shipments · $80.69
34	Nov 2025	EMIRATES POST GROUP	United Arab Emirates	Tablet	10	NOS	$0.812	$8.12	MUMBAI AIR (SAHAR)	DUBAI	AIR
35	Nov 2025	EMIRATES POST GROUP	United Arab Emirates	Other	9	NOS	$1.35	$12.13	MUMBAI AIR (SAHAR)	DUBAI	AIR
36	Dec 2025	EMIRATES POST GROUP	United Arab Emirates	Tablet	18	NOS	$1.30	$23.40	MUMBAI AIR (SAHAR)	DUBAI	AIR
37	Dec 2025	EMIRATES POST GROUP	United Arab Emirates	Tablet	20	NOS	$1.35	$27.00	MUMBAI AIR (SAHAR)	DUBAI	AIR
38	Dec 2025	EMIRATES POST GROUP	United Arab Emirates	Tablet	12	NOS	$0.837	$10.04	MUMBAI AIR (SAHAR)	DUBAI	AIR
39	Dec 2025	EMIRATES POST GROUP	United Arab Emirates	Tablet	10	NOS	$0.0001	$0.0011	MUMBAI AIR (SAHAR)	DUBAI	AIR
SUPPLIER #13 — CLOVERLEAF ECOM PVT LTD · 1 shipments · $5.59
40	Nov 2025	EMIRATES POST GROUP	United Arab Emirates		5	NOS	$1.12	$5.59	MUMBAI AIR (SAHAR)	DUBAI	AIR

10

PART VI — DRILL-DOWN · EUROPE

Region: Europe

8 countries · 59 shipments · $137K · 3 Indian suppliers · 8 buyers

SHIPMENTS

59

USD

$137K

COUNTRIES

8

SUPPLIERS

3

BUYERS

8

HHI

5,629

concentrated

Top 8 destination countries in Europe

1

Poland (32.5%)

$45K

2

Croatia (20.5%)

$28K

3

United Kingdom (17.5%)

$24K

4

Austria (13.7%)

$19K

5

Hungary (10.3%)

$14K

6

Greece (2.9%)

$4K

7

Netherlands (2.6%)

$4K

8

Spain (0.0%)

$53.58

Top 3 Indian suppliers into Europe

1

INTAS PHARMACEUTICALS LTD

$99K

2

MICRO LABS LTD

$24K

3

MYLAN LABORATORIES LTD

$14K

Top 6 Europe importers

1

MYLAN HUNGARY KFT · Hungary

$14K

2

BROWN AND BURK UK LTD · United Kingdom

$13K

3

BROWN AND BURK UK LIMITEDMICRO HOUS · United Kingdom

$11K

4

ACCORD HEALTHCARE POLSKA SP. Z O.O · Poland

$6K

5

BROCACEF NL:EU HUB · Netherlands

$2K

6

ACCORD HEALTHCARE SINGLE MEMBER SA · Greece

$39.22

Top 2 dosage forms

1

Tablet

$122K

2

Unknown

$16K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	13	$37K	$3K
Nov	33	$101K	$3K
Dec	13	$276.79	$21.29

Shipment register · 59 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 55 shipments · $99K
1	Oct 2025	UNLISTED BUYER	Poland	Tablet	290.3K	TBS	$0.016	$5K	MUNDRA SEA	Gdansk	SEA
2	Oct 2025	UNLISTED BUYER	Poland	Tablet	1.8K	TBS	$0.016	$28.10	MUNDRA SEA	Gdansk	SEA
3	Oct 2025	UNLISTED BUYER	Poland	Tablet	71.0K	TBS	$0.027	$2K	MUNDRA SEA	Gdansk	SEA
4	Oct 2025	UNLISTED BUYER	Poland	Tablet	870	TBS	$0.027	$23.62	MUNDRA SEA	Gdansk	SEA
5	Oct 2025	UNLISTED BUYER	Poland	Tablet	66.5K	TBS	$0.016	$1K	MUNDRA SEA	Gdansk	SEA
6	Oct 2025	UNLISTED BUYER	Poland	Tablet	70.1K	TBS	$0.021	$1K	MUNDRA SEA	Gdansk	SEA
7	Oct 2025	UNLISTED BUYER	Poland	Tablet	1.3K	TBS	$0.021	$26.77	MUNDRA SEA	Gdansk	SEA
8	Oct 2025	UNLISTED BUYER	Poland	Tablet	585.6K	TBS	$0.022	$13K	MUNDRA SEA	Gdansk	SEA
9	Oct 2025	UNLISTED BUYER	Poland	Tablet	990	TBS	$0.022	$21.32	MUNDRA SEA	Gdansk	SEA
10	Oct 2025	UNLISTED BUYER	Poland	Tablet	1.8K	TBS	$0.016	$27.99	MUNDRA SEA	Gdansk	SEA
11	Oct 2025	UNLISTED BUYER	Greece	Tablet	177.2K	TBS	$0.022	$4K	MUNDRA SEA	Piraeus	SEA
12	Oct 2025	UNLISTED BUYER	Greece	Tablet	980	TBS	$0.022	$21.73	MUNDRA SEA	Piraeus	SEA
13	Nov 2025	ACCORD HEALTHCARE POLSKA SP. Z O.O	Poland	Tablet	280.3K	TBS	$0.021	$6K	DELHI AIR	WARSAW	AIR
14	Nov 2025	ACCORD HEALTHCARE POLSKA SP. Z O.O	Poland	Tablet	990	TBS	$0.021	$20.57	DELHI AIR	WARSAW	AIR
15	Nov 2025	UNKNOWN BUYER	Poland	Tablet	280.3K	TBS	$0.021	$6K	DELHI AIR	WARSAW	AIR
16	Nov 2025	UNKNOWN BUYER	Poland	Tablet	990	TBS	$0.021	$20.57	DELHI AIR	WARSAW	AIR
17	Nov 2025	BROCACEF NL:EU HUB	Netherlands		104.2K	TBS	$0.017	$2K	MUNDRA SEA	Rotterdam	SEA
18	Nov 2025	BROCACEF NL:EU HUB	Netherlands		1.5K	TBS	$0.017	$24.76	MUNDRA SEA	Rotterdam	SEA
19	Nov 2025	UNLISTED BUYER	Croatia		391.6K	TBS	$0.035	$14K	DELHI AIR	ZAGREB	AIR
20	Nov 2025	UNLISTED BUYER	Croatia		5.5K	TBS	$0.035	$192.29	DELHI AIR	ZAGREB	AIR
21	Nov 2025	UNKNOWN BUYER	Netherlands	Tablet	104.2K	TBS	$0.017	$2K	MUNDRA SEA	Rotterdam	SEA
22	Nov 2025	UNKNOWN BUYER	Netherlands	Tablet	1.5K	TBS	$0.017	$24.76	MUNDRA SEA	Rotterdam	SEA
23	Nov 2025	UNKNOWN BUYER	Croatia	Tablet	391.6K	TBS	$0.035	$14K	DELHI AIR	ZAGREB	AIR
24	Nov 2025	UNKNOWN BUYER	Croatia	Tablet	5.5K	TBS	$0.035	$192.29	DELHI AIR	ZAGREB	AIR
25	Nov 2025	UNLISTED BUYER	Poland	Tablet	162.7K	TBS	$0.022	$4K	MUNDRA SEA	Gdynia	SEA
26	Nov 2025	UNLISTED BUYER	Poland	Tablet	990	TBS	$0.022	$21.78	MUNDRA SEA	Gdynia	SEA
27	Nov 2025	UNLISTED BUYER	Poland	Tablet	116.9K	TBS	$0.017	$2K	MUNDRA SEA	Gdynia	SEA
28	Nov 2025	UNLISTED BUYER	Poland	Tablet	1.5K	TBS	$0.017	$24.67	MUNDRA SEA	Gdynia	SEA
29	Nov 2025	UNKNOWN BUYER	Poland	Tablet	162.7K	TBS	$0.022	$4K	MUNDRA SEA	Gdynia	SEA
30	Nov 2025	UNKNOWN BUYER	Poland	Tablet	990	TBS	$0.022	$21.78	MUNDRA SEA	Gdynia	SEA
31	Nov 2025	UNKNOWN BUYER	Poland	Tablet	116.9K	TBS	$0.017	$2K	MUNDRA SEA	Gdynia	SEA
32	Nov 2025	UNKNOWN BUYER	Poland	Tablet	1.5K	TBS	$0.017	$24.67	MUNDRA SEA	Gdynia	SEA
33	Nov 2025	UNLISTED BUYER	Spain	Tablet	480	TBS	$0.014	$6.92	DELHI AIR	BARCELONA	AIR
34	Nov 2025	UNLISTED BUYER	Spain	Tablet	560	TBS	$0.014	$7.93	DELHI AIR	BARCELONA	AIR
35	Nov 2025	UNLISTED BUYER	United Kingdom	Tablet	504	TBS	$0.015	$7.41	DELHI AIR	LONDON - HEATHROW	AIR
36	Nov 2025	UNLISTED BUYER	United Kingdom	Tablet	448	TBS	$0.018	$8.20	DELHI AIR	LONDON - HEATHROW	AIR
37	Nov 2025	UNLISTED BUYER	Spain	Tablet	480	TBS	$0.014	$6.92	DELHI AIR	BARCELONA	AIR
38	Nov 2025	UNLISTED BUYER	Spain	Tablet	560	TBS	$0.014	$7.93	DELHI AIR	BARCELONA	AIR
39	Nov 2025	UNLISTED BUYER	Austria	Tablet	634.6K	TBS	$0.021	$14K	MUNDRA SEA	Genoa	SEA
40	Nov 2025	UNLISTED BUYER	Austria	Tablet	990	TBS	$0.021	$21.16	MUNDRA SEA	Genoa	SEA
41	Nov 2025	UNLISTED BUYER	Austria	Tablet	243.8K	TBS	$0.021	$5K	MUNDRA SEA	Genoa	SEA
42	Nov 2025	UNLISTED BUYER	Austria	Tablet	990	TBS	$0.021	$21.14	MUNDRA SEA	Genoa	SEA
43	Dec 2025	UNLISTED BUYER	United Kingdom	Tablet	448	TBS	$0.019	$8.72	DELHI AIR	LONDON - HEATHROW	AIR
44	Dec 2025	UNLISTED BUYER	United Kingdom	Tablet	448	TBS	$0.019	$8.72	DELHI AIR	LONDON - HEATHROW	AIR
45	Dec 2025	UNLISTED BUYER	Spain	Tablet	480	TBS	$0.015	$7.14	DELHI AIR	BARCELONA	AIR
46	Dec 2025	UNLISTED BUYER	Spain	Tablet	448	TBS	$0.019	$8.48	DELHI AIR	BARCELONA	AIR
47	Dec 2025	UNLISTED BUYER	Spain	Tablet	720	TBS	$0.011	$8.25	DELHI AIR	BARCELONA	AIR
48	Dec 2025	ACCORD HEALTHCARE SINGLE MEMBER SA	Greece	Tablet	180.5K	TBS	$0.0002	$39.01	MUNDRA SEA	Piraeus	SEA
49	Dec 2025	ACCORD HEALTHCARE SINGLE MEMBER SA	Greece	Tablet	980	TBS	$0.0002	$0.212	MUNDRA SEA	Piraeus	AIR
50	Dec 2025	UNLISTED BUYER	Austria	Tablet	193.2K	TBS	$0.0002	$31.44	MUNDRA SEA	Genoa	SEA
51	Dec 2025	UNLISTED BUYER	Austria	Tablet	1.5K	TBS	$0.0002	$0.239	MUNDRA SEA	Genoa	AIR
52	Dec 2025	BROCACEF NL:EU HUB	Netherlands	Tablet	52.1K	TBS	$0.0002	$10.46	MUNDRA SEA	Rotterdam	SEA
53	Dec 2025	BROCACEF NL:EU HUB	Netherlands	Tablet	1.0K	TBS	$0.0002	$0.208	MUNDRA SEA	Rotterdam	AIR
54	Dec 2025	UNLISTED BUYER	Croatia	Tablet	411.3K	TBS	$0.0004	$151.89	DELHI AIR	ZAGREB	AIR
55	Dec 2025	UNLISTED BUYER	Croatia	Tablet	5.5K	TBS	$0.0004	$2.02	DELHI AIR	ZAGREB	SEA
SUPPLIER #2 — MICRO LABS LTD · 3 shipments · $24K
56	Oct 2025	BROWN AND BURK UK LIMITEDMICRO HOUS	United Kingdom	Tablet	15.9K	PCS	$0.682	$11K	NHAVA SHEVA SEA (JNPT)	LONDON GATWAY PORT	SEA
57	Nov 2025	BROWN AND BURK UK LTD	United Kingdom	Tablet	12.2K	PCS	$0.542	$7K	NHAVA SHEVA SEA (JNPT)	LONDON GATWAY PORT	SEA
58	Nov 2025	BROWN AND BURK UK LTD	United Kingdom	Tablet	11.9K	PCS	$0.551	$7K	NHAVA SHEVA SEA (JNPT)	LONDON GATWAY PORT	SEA
SUPPLIER #3 — MYLAN LABORATORIES LTD · 1 shipments · $14K
59	Nov 2025	MYLAN HUNGARY KFT	Hungary	Tablet	315.8K	NOS	$0.045	$14K	MUMBAI AIR (SAHAR)	BUDAPEST,	AIR

10

PART VI — DRILL-DOWN · AMERICAS

Region: Americas

7 countries · 73 shipments · $2.08M · 8 Indian suppliers · 16 buyers

SHIPMENTS

73

USD

$2.08M

COUNTRIES

7

SUPPLIERS

8

BUYERS

16

HHI

6,239

concentrated

Top 7 destination countries in Americas

1

United States (77.2%)

$1.60M

2

Brazil (19.3%)

$402K

3

Jamaica (1.3%)

$26K

4

Canada (0.9%)

$19K

5

Peru (0.8%)

$16K

6

Dominican Republic (0.3%)

$6K

7

Chile (0.2%)

$4K

Top 8 Indian suppliers into Americas

1

AUROBINDO PHARMA LTD

$1.59M

2

MACLEODS PHARMACEUTICALS LTD

$420K

3

IND SWIFT LTD

$22K

4

LINCOLN PHARMACEUTICALS LTD

$19K

5

KWALITY PHARMACEUTICALS LTD

$16K

6

WESTCOAST PHARMACEUTICAL WORKS LTD

$6K

7

RYVIS PHARMA PVT LTD

$5K

8

ARISTO PHARMACEUTICALS PVT LTD

$4K

Top 15 Americas importers

1

RISING PHARMA HOLDINGS INC · United States

$789K

2

MACLEODS PHARMA USA INC · United States

$420K

3

AUROLOGISTICS LLC · United States

$229K

4

AUROBINDO PHARMA USA INC · United States

$166K

5

MYRALIS INDUSTRIA FARMACEUTICA · Brazil

$137K

6

LABORATORIO TEUTO BRASILEIRO S/A · Brazil

$136K

7

BIOLAB SA · Brazil

$96K

8

LABORATORIO GLOBO SA · Brazil

$33K

9

INDIES PHARMA JAMAICA LTD · Jamaica

$22K

10

J.P.CCANADA CANADACANADA · Canada

$19K

11

AXIERTA CAL. EMETE RIO PEREZ · Peru

$16K

12

RPPL · Jamaica

$5K

13

SOUTH AMERICAN EXPRESS S.A · Chile

$4K

14

NORTHSTAR DISTRIBUTION CENTER · United States

$159.82

15

AUROBINDO PHARMA INDUSTRIA · Brazil

$2.83

Top 2 dosage forms

1

Tablet

$2.08M

2

Other

$2.83

Monthly trend

Month	Ships	USD	Avg/ship
Oct	34	$891K	$26K
Nov	11	$196K	$18K
Dec	28	$990K	$35K

Shipment register · 73 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — AUROBINDO PHARMA LTD · 36 shipments · $1.59M
1	Oct 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	2.6M	NOS	$0.028	$73K	HYDERABAD ICD	NEWARK	ICD
2	Oct 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	2.9M	NOS	$0.021	$60K	HYDERABAD ICD	NEWARK	ICD
3	Oct 2025	AUROBINDO PHARMA USA INC	United States	Tablet	1.6M	NOS	$0.015	$23K	HYDERABAD ICD	NEWARK APT/NEW YORK	ICD
4	Oct 2025	BIOLAB SA	Brazil	Tablet	1.0M	NOS	$0.036	$37K	HYDERABAD AIR	Guarulhos	AIR
5	Oct 2025	BIOLAB SA	Brazil	Tablet	1.1M	NOS	$0.040	$45K	HYDERABAD AIR	Guarulhos	AIR
6	Oct 2025	BIOLAB SA	Brazil	Tablet	707.9K	NOS	$0.020	$14K	HYDERABAD AIR	Guarulhos	AIR
7	Oct 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	639.4K	NOS	$0.015	$10K	HYDERABAD ICD	NEWARK	ICD
8	Oct 2025	AUROBINDO PHARMA INDUSTRIA	Brazil	Other	1	NOS	$2.83	$2.83	HYDERABAD AIR	Guarulhos	AIR
9	Oct 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	756.0K	NOS	$0.029	$22K	HYDERABAD ICD	NEWARK	ICD
10	Oct 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	6.8M	NOS	$0.021	$141K	HYDERABAD ICD	NEWARK	ICD
11	Oct 2025	AUROLOGISTICS LLC	United States	Tablet	527.0K	NOS	$0.020	$11K	HYDERABAD ICD	NEW YORK	ICD
12	Oct 2025	AUROLOGISTICS LLC	United States	Tablet	3.1M	NOS	$0.030	$91K	HYDERABAD ICD	NEW YORK	ICD
13	Oct 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	4.2M	NOS	$0.029	$124K	HYDERABAD ICD	NEW YORK	ICD
14	Oct 2025	LABORATORIO GLOBO SA	Brazil	Tablet	931.2K	TBS	$0.036	$33K	HYDERABAD AIR	GUARULHOS	AIR
15	Oct 2025	AUROBINDO PHARMA USA INC	United States	Tablet	2.6M	NOS	$0.026	$68K	HYDERABAD ICD	Newark Apt/New York	ICD
16	Oct 2025	AUROBINDO PHARMA USA INC	United States	Tablet	900.0K	NOS	$0.015	$13K	HYDERABAD ICD	Newark Apt/New York	ICD
17	Oct 2025	AUROBINDO PHARMA USA INC	United States	Tablet	888.0K	NOS	$0.029	$26K	HYDERABAD ICD	Newark Apt/New York	ICD
18	Dec 2025	LABORATORIO TEUTO BRASILEIRO S/A	Brazil	Tablet	738.6K	NOS	$0.023	$17K	HYDERABAD ICD	SANTOS	ICD
19	Dec 2025	LABORATORIO TEUTO BRASILEIRO S/A	Brazil	Tablet	1.2M	NOS	$0.045	$54K	HYDERABAD ICD	SANTOS	ICD
20	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	455.0K	NOS	$0.018	$8K	HYDERABAD ICD	NEW YORK	ICD
21	Dec 2025	LABORATORIO TEUTO BRASILEIRO S/A	Brazil	Tablet	364.8K	NOS	$0.023	$8K	HYDERABAD ICD	SANTOS	ICD
22	Dec 2025	LABORATORIO TEUTO BRASILEIRO S/A	Brazil	Tablet	1.2M	NOS	$0.046	$57K	HYDERABAD ICD	SANTOS	ICD
23	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	5.3M	NOS	$0.014	$73K	HYDERABAD ICD	NEW YORK	ICD
24	Dec 2025	MYRALIS INDUSTRIA FARMACEUTICA	Brazil	Tablet	1.6M	NOS	$0.042	$68K	HYDERABAD ICD	SANTOS	ICD
25	Dec 2025	MYRALIS INDUSTRIA FARMACEUTICA	Brazil	Tablet	609.6K	NOS	$0.041	$25K	HYDERABAD ICD	SANTOS	ICD
26	Dec 2025	MYRALIS INDUSTRIA FARMACEUTICA	Brazil	Tablet	1.2M	NOS	$0.037	$44K	HYDERABAD ICD	SANTOS	ICD
27	Dec 2025	AUROBINDO PHARMA USA INC	United States	Tablet	1.3M	NOS	$0.027	$35K	HYDERABAD ICD	NEWARK APT/NEW YORK	ICD
28	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	933.1K	NOS	$0.023	$22K	HYDERABAD ICD	NEWARK	ICD
29	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	5.6M	NOS	$0.021	$120K	HYDERABAD ICD	NEWARK	ICD
30	Dec 2025	AUROLOGISTICS LLC	United States	Tablet	3.1M	NOS	$0.030	$95K	HYDERABAD ICD	NEW YORK	ICD
31	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	377.3K	NOS	$0.034	$13K	HYDERABAD ICD	NEW YORK	ICD
32	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	1.3M	NOS	$0.016	$20K	HYDERABAD ICD	NEW YORK	ICD
33	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	495.0K	NOS	$0.014	$7K	HYDERABAD ICD	NEW YORK	ICD
34	Dec 2025	AUROLOGISTICS LLC	United States	Tablet	427.7K	NOS	$0.016	$7K	HYDERABAD ICD	NEWARK	ICD
35	Dec 2025	AUROLOGISTICS LLC	United States	Tablet	1.7M	NOS	$0.015	$26K	HYDERABAD ICD	NEWARK	ICD
36	Dec 2025	RISING PHARMA HOLDINGS INC	United States	Tablet	3.2M	NOS	$0.030	$97K	HYDERABAD ICD	NEWARK	ICD
SUPPLIER #2 — MACLEODS PHARMACEUTICALS LTD · 19 shipments · $420K
37	Oct 2025	MACLEODS PHARMA USA INC	United States	Tablet	136.8K	NOS	$0.019	$3K	CHAWAPAYAL ICD	SAVANNAH	ICD
38	Oct 2025	MACLEODS PHARMA USA INC	United States	Tablet	291.6K	NOS	$0.024	$7K	CHAWAPAYAL ICD	SAVANNAH	ICD
39	Oct 2025	MACLEODS PHARMA USA INC	United States	Tablet	284.4K	NOS	$0.024	$7K	CHAWAPAYAL ICD	SAVANNAH	ICD
40	Oct 2025	MACLEODS PHARMA USA INC	United States	Tablet	280.8K	NOS	$0.030	$8K	CHAWAPAYAL ICD	SAVANNAH	ICD
41	Oct 2025	MACLEODS PHARMA USA INC	United States	Tablet	284.4K	NOS	$0.024	$7K	DADRI ICD	SAVANNAH	ICD
42	Oct 2025	MACLEODS PHARMA USA INC	United States	Tablet	406.8K	NOS	$0.019	$8K	CHAWAPAYAL ICD	Savannah	ICD
43	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	1.2M	NOS	$0.016	$19K	CHAWAPAYAL ICD	SAVANNAH	ICD
44	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	588.0K	NOS	$0.017	$10K	CHAWAPAYAL ICD	SAVANNAH	ICD
45	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	2.4M	NOS	$0.016	$37K	CHAWAPAYAL ICD	SAVANNAH	ICD
46	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	1.2M	NOS	$0.017	$20K	CMA CGM LOGISTICS ICD	SAVANNAH	ICD
47	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	588.6K	NOS	$0.023	$13K	CMA CGM LOGISTICS ICD	SAVANNAH	ICD
48	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	3.6M	NOS	$0.017	$61K	CHAWAPAYAL ICD	SAVANNAH	ICD
49	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	1.2M	NOS	$0.017	$20K	CHAWAPAYAL ICD	SAVANNAH	ICD
50	Nov 2025	MACLEODS PHARMA USA INC	United States	Tablet	403.2K	NOS	$0.019	$8K	CHAWAPAYAL ICD	SAVANNAH	ICD
51	Dec 2025	MACLEODS PHARMA USA INC	United States	Tablet	3.9M	NOS	$0.029	$113K	CHAWAPAYAL ICD	SAVANNAH	ICD
52	Dec 2025	MACLEODS PHARMA USA INC	United States	Tablet	972.0K	NOS	$0.030	$29K	CHAWAPAYAL ICD	SAVANNAH	ICD
53	Dec 2025	MACLEODS PHARMA USA INC	United States	Tablet	972.0K	NOS	$0.024	$23K	CHAWAPAYAL ICD	SAVANNAH	ICD
54	Dec 2025	MACLEODS PHARMA USA INC	United States	Tablet	966.0K	NOS	$0.029	$28K	CHAWAPAYAL ICD	SAVANNAH	ICD
55	Dec 2025	NORTHSTAR DISTRIBUTION CENTER	United States	Tablet	576.0K	NOS	$0.0003	$159.82	DELHI AIR	CHICAGO O'HARE INT'L	SEA
SUPPLIER #3 — IND SWIFT LTD · 4 shipments · $22K
56	Oct 2025	INDIES PHARMA JAMAICA LTD	Jamaica	Tablet	13.2K	NOS	$0.0000	$0.089	NHAVA SHEVA SEA (JNPT)	Kingston	SEA
57	Oct 2025	INDIES PHARMA JAMAICA LTD	Jamaica	Tablet	128.1K	NOS	$0.046	$6K	NHAVA SHEVA SEA (JNPT)	Kingston	SEA
58	Oct 2025	INDIES PHARMA JAMAICA LTD	Jamaica	Tablet	6.5K	NOS	$0.0000	$0.039	NHAVA SHEVA SEA (JNPT)	Kingston	SEA
59	Oct 2025	INDIES PHARMA JAMAICA LTD	Jamaica	Tablet	263.1K	NOS	$0.061	$16K	NHAVA SHEVA SEA (JNPT)	Kingston	SEA
SUPPLIER #4 — LINCOLN PHARMACEUTICALS LTD · 3 shipments · $19K
60	Oct 2025	J.P.CCANADA CANADACANADA	Canada	Tablet	864	NOS	$7.39	$6K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
61	Oct 2025	J.P.CCANADA CANADACANADA	Canada	Tablet	1.4K	NOS	$4.48	$6K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
62	Oct 2025	J.P.CCANADA CANADACANADA	Canada	Tablet	1.4K	NOS	$4.89	$7K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
SUPPLIER #5 — KWALITY PHARMACEUTICALS LTD · 2 shipments · $16K
63	Oct 2025	AXIERTA CAL. EMETE RIO PEREZ	Peru	Tablet	300.0K	NOS	$0.027	$8K	TUGHLAKABAD ICD	CALLAO	ICD
64	Oct 2025	AXIERTA CAL. EMETE RIO PEREZ	Peru	Tablet	300.0K	NOS	$0.027	$8K	TUGHLAKABAD ICD	CALLAO	ICD
SUPPLIER #6 — WESTCOAST PHARMACEUTICAL WORKS LTD · 2 shipments · $6K
65	Nov 2025	UNLISTED BUYER	Dominican Republic	Tablet	4.8K	NOS	$0.539	$3K	AHMEDABAD ICD	CAUCEDO DOMINIC REP.	ICD
66	Nov 2025	UNLISTED BUYER	Dominican Republic	Tablet	19.8K	NOS	$0.170	$3K	AHMEDABAD ICD	CAUCEDO DOMINIC REP.	ICD
SUPPLIER #7 — RYVIS PHARMA PVT LTD · 5 shipments · $5K
67	Nov 2025	RPPL	Jamaica	Tablet	1.5K	NOS	$2.10	$3K	NHAVA SHEVA SEA (JNPT)	Kingston	SEA
68	Dec 2025	RPPL	Jamaica	Tablet	170	NOS	$0.494	$84.02	MUMBAI AIR (SAHAR)	KINGSTON	AIR
69	Dec 2025	RPPL	Jamaica	Tablet	2.0K	NOS	$0.357	$710.01	MUMBAI AIR (SAHAR)	KINGSTON	AIR
70	Dec 2025	RPPL	Jamaica	Tablet	1.7K	NOS	$0.391	$652.66	MUMBAI AIR (SAHAR)	KINGSTON	AIR
71	Dec 2025	RPPL	Jamaica	Tablet	5.0K	NOS	$0.0047	$23.30	NHAVA SHEVA SEA (JNPT)	Kingston	SEA
SUPPLIER #8 — ARISTO PHARMACEUTICALS PVT LTD · 2 shipments · $4K
72	Oct 2025	SOUTH AMERICAN EXPRESS S.A	Chile	Tablet	4.0K	NOS	$0.268	$1K	NHAVA SHEVA SEA (JNPT)	La Paz	SEA
73	Oct 2025	SOUTH AMERICAN EXPRESS S.A	Chile	Tablet	1.5K	NOS	$2.08	$3K	NHAVA SHEVA SEA (JNPT)	La Paz	SEA

10

PART VI — DRILL-DOWN · OCEANIA

Region: Oceania

2 countries · 2 shipments · $145.41 · 2 Indian suppliers · 2 buyers

SHIPMENTS

2

USD

$145.41

COUNTRIES

2

SUPPLIERS

2

BUYERS

2

HHI

10,000

concentrated

Top 2 destination countries in Oceania

1

Australia (100.0%)

$145.41

2

Micronesia · Micronesia

$0.0000

Top 2 Indian suppliers into Oceania

1

IND SWIFT LABORATORIES LTD

$145.41

2

ANBU AGENCIES

$0.0000

Top 2 Oceania importers

1

APOTEX PTY LTD · Australia

$145.41

2

THE MANAGER SA · Micronesia

$0.0000

Top 1 dosage forms

1

Tablet

$145.41

Monthly trend

Month	Ships	USD	Avg/ship
Oct	0	$0.0000	—
Nov	0	$0.0000	—
Dec	2	$145.41	$72.71

Shipment register · 2 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — IND SWIFT LABORATORIES LTD · 1 shipments · $145.41
1	Dec 2025	APOTEX PTY LTD	Australia	Tablet	201.6K	NOS	$0.0007	$145.41	DELHI AIR	SYDNEY, NS	AIR
SUPPLIER #2 — ANBU AGENCIES · 1 shipments · $0.0000
2	Dec 2025	THE MANAGER SA	Micronesia	Tablet	20	NOS	$0.0000	$0.0000	CHENNAI AIR	POHNPEI	AIR

10

PART VI — EVIDENCE REGISTER

Indian Supplier Directory

All 25 Indian pioglitazone exporters — complete list ranked by USD

KEY TAKEAWAY This directory lists every Indian company that shipped pioglitazone in 2025-Q4.

S FOR SUPPLIERS

Find yourself and your competitors. Compare shipment count, USD, and destination regions.

B FOR BUYERS

Search for potential Indian suppliers. Filter by dosage form and destination region.

#	Supplier	City	Ships	USD	Dosage forms	Primary regions
1	AUROBINDO PHARMA LTD	HYDERABAD	36	$1.59M	Tablet, Other	Americas
2	MACLEODS PHARMACEUTICALS LTD	BADDI	21	$444K	Tablet	Americas, Africa
3	MICRO LABS LTD	HOSUR	7	$107K	Tablet	Asia, Europe
4	INTAS PHARMACEUTICALS LTD	AHMEDABAD	55	$99K	Tablet	Europe
5	IND SWIFT LABORATORIES LTD	SAS Nagar	5	$92K	Tablet	Asia, Oceania
6	USV PVT LTD	MUMBAI	6	$42K	Tablet	Asia
7	THE MADRAS PHARMACEUTICALS	CHENNAI	6	$31K	Tablet	Asia, Africa
8	MEDLEY PHARMACEUTICALS LTD	MUMBAI	5	$28K	Tablet	Asia
9	IND SWIFT LTD	CHANDIGARH.	4	$22K	Tablet	Americas
10	LINCOLN PHARMACEUTICALS LTD	AHMEDABAD	3	$19K	Tablet	Americas
11	KWALITY PHARMACEUTICALS LTD	AMRITSAR	2	$16K	Tablet	Americas
12	ARISTO PHARMACEUTICALS PVT LTD	RAISEN	6	$15K	Tablet	Asia, Americas
13	MYLAN LABORATORIES LTD	NASHIK	1	$14K	Tablet	Europe
14	SAGA LIFESCIENCES LTD	TALUKA SANAND	2	$12K	Tablet	Asia
15	UMEDICA LABORATORIES PVT LTD	GUJARAT	2	$11K	Tablet	Asia
16	WESTCOAST PHARMACEUTICAL WORKS LTD	AHMEDABAD	2	$6K	Tablet	Americas
17	UNOSOURCE PHARMA LTD	MUMBAI	1	$5K	Tablet	Asia
18	RYVIS PHARMA PVT LTD	Mumbai	5	$5K	Tablet	Americas
19	MASCOT HEALTH SERIES PVT LTD	HARIDWAR	1	$2K	Tablet	Africa
20	SANITAS MEDTECH INSTITUTE PVT LTD	Narhen	1	$844.71	Tablet	Asia
21	ZEAL PHARMA	NEW KOSAD ROAD AMROLI	2	$94.94	Tablet	Asia
22	FALCON TRANSGLOBAL	NAGPUR	6	$80.69	Tablet, Other	Asia
23	CLOVERLEAF ECOM PVT LTD	NAGPUR	1	$5.59		Asia
24	MEDICOS LIFESCIENCES	AHMEDABAD	1	$0.610	Tablet	Africa
25	ANBU AGENCIES	NAGERCOIL	1	$0.0000	Tablet	Oceania

10

PART VI — EVIDENCE REGISTER

Global Buyer Directory

All 43 global pioglitazone importers — complete list ranked by USD

KEY TAKEAWAY This directory lists every company that imported Indian pioglitazone in 2025-Q4.

S FOR SUPPLIERS

Search for potential customers by country and dosage form.

B FOR BUYERS

Find your company and see which Indian supplier serves you.

#	Buyer	Country	Ships	USD	Primary supplier	Dosage forms
1	RISING PHARMA HOLDINGS INC	United States	14	$789K	AUROBINDO PHARMA LTD	Tablet
2	MACLEODS PHARMA USA INC	United States	18	$420K	MACLEODS PHARMACEUTI…	Tablet
3	AUROLOGISTICS LLC	United States	5	$229K	AUROBINDO PHARMA LTD	Tablet
4	AUROBINDO PHARMA USA INC	United States	5	$166K	AUROBINDO PHARMA LTD	Tablet
5	MYRALIS INDUSTRIA FARMACEUTICA	Brazil	3	$137K	AUROBINDO PHARMA LTD	Tablet
6	LABORATORIO TEUTO BRASILEIRO S/A	Brazil	4	$136K	AUROBINDO PHARMA LTD	Tablet
7	BIOLAB SA	Brazil	3	$96K	AUROBINDO PHARMA LTD	Tablet
8	NEW COUNTRY HEALTHCARE LLC	United Arab Emirates	1	$60K	IND SWIFT LABORATORI…	Tablet
9	LABORATORIO GLOBO SA	Brazil	1	$33K	AUROBINDO PHARMA LTD	Tablet
10	MICRO MEGA LANKA (PRIVATE) LTD	Sri Lanka	2	$33K	MICRO LABS LTD	Tablet
11	MICRO NOVA PHARMACEUTICALS IND	Nigeria	1	$31K	MICRO LABS LTD	Tablet
12	HEMAS PHARMACEUTICALS (PVT) LTD	Sri Lanka	2	$30K	USV PVT LTD	Tablet
13	MACLEODS PHARMACEUTICALS SA	South Africa	2	$24K	MACLEODS PHARMACEUTI…	Tablet
14	INDIES PHARMA JAMAICA LTD	Jamaica	4	$22K	IND SWIFT LTD	Tablet
15	AMBICA INTERNATIONAL CORP	Philippines	3	$20K	MEDLEY PHARMACEUTICA…	Tablet
16	J.P.CCANADA CANADACANADA	Canada	3	$19K	LINCOLN PHARMACEUTIC…	Tablet
17	OEP PHILIPPINES INC	Philippines	1	$19K	MICRO LABS LTD	Tablet
18	AXIERTA CAL. EMETE RIO PEREZ	Peru	2	$16K	KWALITY PHARMACEUTIC…	Tablet
19	LIFE PHARMA FZE	United Arab Emirates	1	$16K	IND SWIFT LABORATORI…	Tablet
20	STATE PHARMACEUTICALS CORP	Sri Lanka	1	$16K	THE MADRAS PHARMACEU…	Tablet
21	MYLAN HUNGARY KFT	Hungary	1	$14K	MYLAN LABORATORIES LTD	Tablet
22	BROWN AND BURK UK LTD	United Kingdom	2	$13K	MICRO LABS LTD	Tablet
23	PHARMACHEM PVT LTD	Nepal	4	$12K	USV PVT LTD	Tablet
24	BROWN AND BURK UK LIMITEDMICRO HOUS	United Kingdom	1	$11K	MICRO LABS LTD	Tablet
25	PLANET PHARMACEUTICAL LTD	Tanzania	2	$10K	ARISTO PHARMACEUTICA…	Tablet
26	MEDINOVA PHARMACEUTICAL INC	Philippines	1	$8K	IND SWIFT LABORATORI…	Tablet
27	ACCORD HEALTHCARE POLSKA SP. Z O.O	Poland	2	$6K	INTAS PHARMACEUTICAL…	Tablet
28	M/S.PHARMA ASSOCIATES	Sri Lanka	2	$5K	THE MADRAS PHARMACEU…	Tablet
29	LYMENS MEDICAL SUPPLIES LTD	Ghana	1	$5K	THE MADRAS PHARMACEU…	Tablet
30	RPPL	Jamaica	5	$5K	RYVIS PHARMA PVT LTD	Tablet
31	SOUTH AMERICAN EXPRESS S.A	Chile	2	$4K	ARISTO PHARMACEUTICA…	Tablet
32	LYMENS MEDICAL SUPPLY LTD	Ghana	1	$2K	MASCOT HEALTH SERIES…	Tablet
33	BROCACEF NL:EU HUB	Netherlands	4	$2K	INTAS PHARMACEUTICAL…	Tablet
34	ADK PHARMACEUTICAL COMPANY PVT LTD	Maldives	2	$2K	MEDLEY PHARMACEUTICA…	Tablet
35	UNIQUE TRADE LINK PVT LTD	Nepal	2	$1K	ARISTO PHARMACEUTICA…	Tablet
36	SUCCESS INTER LINK PTE LTD	Singapore	1	$844.71	SANITAS MEDTECH INST…	Tablet
37	NORTHSTAR DISTRIBUTION CENTER	United States	1	$159.82	MACLEODS PHARMACEUTI…	Tablet
38	APOTEX PTY LTD	Australia	1	$145.41	IND SWIFT LABORATORI…	Tablet
39	EMIRATES POST GROUP	United Arab Emirates	7	$86.28	FALCON TRANSGLOBAL	Tablet, Other
40	ACCORD HEALTHCARE SINGLE MEMBER SA	Greece	2	$39.22	INTAS PHARMACEUTICAL…	Tablet
41	AUROBINDO PHARMA INDUSTRIA	Brazil	1	$2.83	AUROBINDO PHARMA LTD	Other
42	LUSAKA PHARMA CHEM SUPPLIES LTD	Zambia	1	$0.610	MEDICOS LIFESCIENCES	Tablet
43	THE MANAGER SA	Micronesia	1	$0.0000	ANBU AGENCIES	Tablet

This report covers 182 2025-Q4 Pioglitazone shipments. TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020. → transdatanexus.com/pharmaceutical/pioglitazone

Talk to our trade analyst

Need a custom pioglitazone report or a deeper dive into any market? Our team is ready.

WhatsApp: +91 95950 78788 · transdatanexus.com

PHARMA TRADE INTELLIGENCE

Thank you for reading

This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.

Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.

Need a custom report?

We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.

Want deeper analysis?

Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.

Scan for product page

WhatsApp: +91 95950 78788

Email: info@transdatanexus.com

Web: https://transdatanexus.com/pharmaceutical/pioglitazone

© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only. Data sourced from official customs filings and licensed commercial trade databases. Reproduction without permission is prohibited.

Pioglitazone — Export Intelligence Report

Pioglitazone

§2.1 Reporting parameters · the scope of this 2025-Q4 Pioglitazone India trade report

§2.2 Our quality process · Figure 2.1

§2.3 Trust signals · what you can rely on in the numbers you read

§2.4 Limitations · what the data does and does not tell you

§3.1 Monthly summary

§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers

§4.2 Destination concentration

Product variety — how many formulations each supplier ships

§5.1 Supplier concentration metrics

§5.2 Coming next: 9 exporter deep-dive profiles

AUROBINDO PHARMA LTD — Supplier → Country → Importer

MACLEODS PHARMACEUTICALS LTD — Supplier → Country → Importer

MICRO LABS LTD — Supplier → Country → Importer

INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer

IND SWIFT LABORATORIES LTD — Supplier → Country → Importer

USV PVT LTD — Supplier → Country → Importer

THE MADRAS PHARMACEUTICALS — Supplier → Country → Importer

MEDLEY PHARMACEUTICALS LTD — Supplier → Country → Importer

ARISTO PHARMACEUTICALS PVT LTD — Supplier → Country → Importer

§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?

§6.2 Single-source lock-in by country

§6.3 Price positioning — top 25 importers

§7.1 Price distribution · Table 7.1

§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices

§7.3 Procurement cheat sheet — median USD/unit by country × dosage

§8.1 Reference transit times for key India → global corridors

§9.1 Single-source dependencies

§9.2 Multi-source resilience

§9.3 Sourcing recommendations · Table 9.1

§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers

§10.1 Global totals

§10.2 Regional breakdown

§10.3 Key insights from the data

§10.4 How to read a country page

Top 5 destination countries in Africa

Top 6 Indian suppliers into Africa

Top 6 Africa importers

Top 1 dosage forms

Monthly trend

Shipment register · 8 rows · grouped by exporter

Top 8 destination countries in Asia

Top 13 Indian suppliers into Asia

Top 14 Asia importers

Top 3 dosage forms

Monthly trend

Shipment register · 40 rows · grouped by exporter

Top 8 destination countries in Europe

Top 3 Indian suppliers into Europe

Top 6 Europe importers

Top 2 dosage forms

Monthly trend

Shipment register · 59 rows · grouped by exporter

Top 7 destination countries in Americas

Top 8 Indian suppliers into Americas

Top 15 Americas importers

Top 2 dosage forms

Monthly trend

Shipment register · 73 rows · grouped by exporter

Top 2 destination countries in Oceania

Top 2 Indian suppliers into Oceania

Top 2 Oceania importers

Top 1 dosage forms

Monthly trend

Shipment register · 2 rows · grouped by exporter

Thank you for reading